1
Clinical Trials associated with DAW-1033B2Effect of DAW1033B2 on Obstructive Sleep Apnea
Obstructive sleep apnea (OSA) is common and has major health implications but treatment options are limited. OSA patients show a marked reduction in upper airway (UA) dilator muscle activity at sleep onset and this phenomenon leads to increased collapsibility of UA compared to normal subjects. In this protocol the investigators will test the effect of DAW1033B2 administered before sleep on OSA phenotype traits and OSA severity during sleep.
100 Clinical Results associated with DAW-1033B2
100 Translational Medicine associated with DAW-1033B2
100 Patents (Medical) associated with DAW-1033B2
100 Deals associated with DAW-1033B2